(TheNewswire)
Vancouver, B.C., - TheNewswire- July 7th, 2022 –Solarvest BioEnergy Inc. (“Solarvest” or the “Company”)(TSXV:SVS) is very pleased to announce that Richard Groome has agreedto chair the Company’s newly created financial advisory committee(the “Advisory Board”) and to support the recruitment of twoadditional members. The Advisory Committee will offer knowledge andskills in relation to fundraising, strategic acquisitions, marketingand to connect Solarvest with potential investors, customers,partners, service providers, employees and media.
CEO Gerri Greenham said “Solarvest has developed somevery exciting and innovative new organic products that can disrupt thestatus quo. In particular, the Organic Omega 3 is a game-changer inthe vast multi-billion USD Omega-3 global marketplace. The addition ofMr. Groome and his wealth of experience in the capital markets willenable us to fully exploit the uniqueness of our products.”
Richard (Rick) Groome, over the last three decades, wasinstrumental in creating and building two securities firms, MarleauLemire and Groome Capital, which funded many successful biotechnologyand nutraceutical companies. Among Mr. Groome's achievementsare:
-
Launching two securities trading andunderwriting houses, with each achieving leading status within 3 yearsand one traded publicly on the Toronto Stock Exchange.
-
Managing and participating in more than600 financings representing some $4 billion of small cap deals, withseveral companies successfully becoming billion andmulti-billion-dollar companies.
-
Serving as past Director of the CDNX,the predecessor of the TSX Venture Exchange.
-
Serving on more than 30 boards ofdirectors of emerging growth companies and experience in corporategovernance and early start-up situations.
Richard Groome added, “I’m excited to chair theSolarvest Advisory Committee and am looking forward to helping theCompany penetrate the Omega-3 global marketplace with their unique newOrganic Omega-3 line of products.“
An aggregate of 1,000,000 stock options exercisable ata price of $0.10 for a period of two years from the date of grant havebeen reserved for members of the Advisory Committee under theCompany’s stock option plan.
AboutSolarvest
Solarvest BioEnergy Inc. is an algaebiologics company whose production platform provides it with anextremely flexible system capable of producing numerous products fromOmega 3 fatty acids to human therapeutic proteins. The Company hassuccessfully developed, and produced the world’s only patentedplant-based organic certifiedOmega-3 to satisfy the substantial demand for this essential nutrient. fermentation facilities.
For further information contact:
Gerri Greenham, CEO
Tel: (647) 204-4095
Email: invest@solarvest.ca
Forward-LookingStatement
This news release containsforward-looking statements, which relate to future events or futureperformance and reflect management's current expectations andassumptions. Such forward-looking statements reflect management'scurrent beliefs and are based on assumptions made by and informationcurrently available to the Company. Investors are cautioned that theseforward looking statements are neither promises nor guarantees, andare subject to risks and uncertainties that may cause future resultsto differ materially from those expected. These forward-lookingstatements are made as of the date hereof and, except as requiredunder applicable securities legislation, the Company does not assumeany obligation to update or revise them to reflect new events orcircumstances.
Neither the TSXVenture Exchange nor its regulation services provider (as that term isdefined in the policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this pressrelease.
Copyright (c) 2022 TheNewswire - All rights reserved.